英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
assembl查看　assembl　在百度字典中的解释百度英翻中〔查看〕
assembl查看　assembl　在Google字典中的解释Google英翻中〔查看〕
assembl查看　assembl　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Xywav for idiopathic hypersomnia: Side effects, cost, and more
    Xywav is also approved to treat excessive daytime sleepiness and cataplexy (sudden muscle weakness) related to narcolepsy Side effects of Xywav when used to treat these narcolepsy-related
  • Idiopathic Hypersomnia Symptoms and Treatment | XYWAV® IH
    IH is a 24-hour condition with multiple symptoms including excessive daytime sleepiness, sleep inertia (severe grogginess or confusion when waking up), cognitive impairment (brain fog), long sleep time, and unrefreshing sleep XYWAV is the first and only FDA-approved medication to treat IH in adults XYWAV has been studied across multiple
  • Xywav: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Xywav is also used in adults to treat idiopathic hypersomnia (IH), which is an uncommon, chronic sleep disorder that causes daytime sleepiness even after a good night's sleep Xywav helps to improve the quality and quantity of deep sleep at night, which reduces excessive daytime sleepiness and the number of sleeping periods during the day and
  • Specialty Guideline Management Xywav - Caremark
    Excessive Daytime Sleepiness (EDS) with Narcolepsy 1-3 Authorization of 12 months may be granted for continued treatment of excessive daytime sleepiness (EDS) with narcolepsy when the member has demonstrated beneficial response to treatment as defined by a decrease in daytime sleepiness with narcolepsy from baseline Idiopathic hypersomnia 1,5
  • FDA-Approved Treatment for Idiopathic Hypersomnia | XYWAV HCP
    XYWAV ® (calcium, magnesium, potassium, and sodium oxybates) oral solution, 0 5 g mL total salts (equivalent to 0 413 g mL of oxybate) is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy, and for the treatment of idiopathic hypersomnia (IH) in adults
  • Jazz Presents New Data on Xywavs Impact on Narcolepsy and IH | Sleep . . .
    Summary: At the 37th annual Psych Congress, Jazz Pharmaceuticals presented results from the phase 4 DUET trial on low-sodium Xywav, showing its effectiveness in treating excessive daytime sleepiness and improving sleep outcomes for adults with narcolepsy and idiopathic hypersomnia Findings indicated notable improvements in polysomnography measures like nighttime awakenings and sleep stage
  • Excessive Daytime Sleepiness Medicine: Causes Treatments
    National Sleep Foundation Excessive Daytime Sleepiness – Narcolepsy and Idiopathic Hypersomnia Updated March 7, 2024 Accessed May 8, 2025
  • Excessive Daytime Sleepiness: Understanding Hypersomnolence Symptoms . . .
    Excessive Daytime Sleepiness (EDS), clinically known as Hypersomnolence Disorder, goes beyond the occasional yawn—it’s a persistent urge to nap or drift off during the day, even after a full night’s sleep Affecting roughly 5% of adults, EDS can hamper work, strain relationships, and increase the risk of accidents
  • Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing . . .
    Xywav is the only low-sodium oxybate approved by the U S Food and Drug Administration for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older





中文字典-英文字典  2005-2009